You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 166 No. 9, May 8, 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Osteoporosis
 •Diabetes Mellitus
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Thiazolidinediones and the Risk of Nontraumatic Fractures in Patients With Diabetes: In Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In their letter published in the January 9, 2006, issue of the ARCHIVES, Mascitelli and Pezzetta1 state that thiazolidinedione use has been shown to decrease hip and femoral neck bone mineral density (BMD)2 and suggest that this is an explanation for our report that adults with type 2 diabetes mellitus are at higher fracture risk compared with adults without diabetes in the Health, Aging, and Body Composition (Health ABC) Study.3 While we agree that thiazolidinedione use may be associated with bone loss, the prevalence of thiazolidinedione use was too low to account for the increased fracture risk associated with type 2 diabetes mellitus that we reported.3 The reference that Mascitelli and Pezzetta1 cite is also from the Health ABC Study,2 and only 11 (2%) of 566 participants with diabetes in our report used a thiazolidinedione at the start of the study in 1997-1998. In the first 4 years . . . [Full Text of this Article]


AUTHOR INFORMATION
Elsa S. Strotmeyer, PhD, MPH; Ann V. Schwartz, PhD; Anne B. Newman, MD, MPH



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Thiazolidinediones and the Risk of Nontraumatic Fractures in Patients With Diabetes
Luca Mascitelli and Francesca Pezzetta
Arch Intern Med. 2006;166(1):126.
EXTRACT | FULL TEXT  

Nontraumatic Fracture Risk With Diabetes Mellitus and Impaired Fasting Glucose in Older White and Black Adults: The Health, Aging, and Body Composition Study
Elsa S. Strotmeyer, Jane A. Cauley, Ann V. Schwartz, Michael C. Nevitt, Helaine E. Resnick, Douglas C. Bauer, Frances A. Tylavsky, Nathalie de Rekeneire, Tamara B. Harris, and Anne B. Newman
Arch Intern Med. 2005;165(14):1612-1617.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.